about
Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazineNuclear ING2 expression is reduced in human cutaneous melanomasOptimal management of metastatic melanoma: current strategies and future directionsThe combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53Characterization of a novel anti-cancer compound for astrocytomasOphiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma CellsRole of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer.Surgical management of the patient with metastatic melanoma to the heart.Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.Silymarin selectively protects human renal cells from cisplatin-induced cell death.A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaPerspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanomaIsolated malignant melanoma metastasis to the pancreas.Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK.Metastatic tumors to the pancreas: The role of surgery.Treatment of in-transit melanoma with intra-lesional interleukin-2: a systematic review.Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.Kaurenic acid: Evaluation of the in vivo and in vitro antitumor activity on murine melanoma.Anti-Proliferative Effect of Rosmarinus officinalis L. Extract on Human Melanoma A375 CellsPromoters with cancer cell-specific activity for melanoma gene therapy.Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease.Breast metastasis from a melanoma.Embryonic signaling in melanoma: potential for diagnosis and therapyOptimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.Immunotherapy of melanoma: a critical review of current concepts and future strategies.Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluationInduction of apoptosis in melanoma A375 cells by a chloroform fraction of Centratherum anthelminticum (L.) seeds involves NF-kappaB, p53 and Bcl-2-controlled mitochondrial signaling pathways.Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.Current clinical overview of cutaneous melanoma.The Critical Role of PPARgamma in Human Malignant MelanomaDNA vaccination and gene therapy: optimization and delivery for cancer therapy.Identifying novel molecular structures for advanced melanoma by ligand-based virtual screening.Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.Pancreatic resection for metastatic melanoma. Case report and review of the literature.Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs.
P2860
Q24313552-68EF838A-7133-4B64-8FE9-DB5C899120E7Q24652926-B869B45F-2753-4BAC-A51C-1741A4D78E7BQ26997338-550CA4AA-84CD-4B2F-B185-1CE16D2FE9AEQ28476737-E4072AB2-5681-47A8-85CD-61CB11DF5C82Q28543237-8BF0EA14-9D20-403A-9C5B-97C8A05FAD2DQ28554921-AF688220-D52E-4B13-A81D-8B1A146F5739Q30274798-DC4DA7D1-9E90-495B-9E26-9B11484E61C8Q30380034-6EB7C3ED-07C3-4EF4-BA6D-522E3D692D31Q33853594-DB230D7C-9105-4106-8518-D6B827C5D558Q33904503-E3781CD7-2AF1-4530-9DD4-DB64457AC4A9Q33960795-1FA18B02-AE9C-4B5A-8598-9F41D204EB32Q33986172-EF4B2396-211A-42A3-A781-FC466EB2E673Q34051168-B0FC09BA-6CC0-4611-80E7-A1B01B251DC3Q34123491-A794597F-40A3-4F6B-94C9-B5F327212C29Q34292167-EE6C3061-DAE2-4ACD-8E5F-A6EE2ABD4028Q34419167-FD52EEF0-3BE2-43DF-9D6B-FD4009A4AC80Q34443793-C03CFABC-7A05-4FE3-BB53-0CDCB52EAD5BQ35201353-4A408EED-6F9A-4644-AC6A-2B1791EBDA03Q35499214-6438F61F-D764-4E0F-AD92-6832C954AE24Q35588855-B75D6927-0D81-44C0-BB19-78086F721D8CQ35590036-AD9AAFAE-4B92-4FFB-AA91-CB459E6254E5Q35692071-BA62D648-FF08-43D1-8296-0F6AD2AA4671Q35944371-CF5B86C6-9AC7-4616-B39E-8A9F98ECFDCBQ36031947-8A98CFEE-74D2-48B5-B1CE-5AEC864052B2Q36071051-A9C32C9A-A3CB-4CAD-B3D7-28E237022BDFQ36239253-766A9EF4-AFA7-423D-A9F4-90AB209C4239Q36265194-30C336F9-D258-430E-AFE3-EF29584153EFQ36526919-27E24804-33B6-4269-B935-49816A062FA7Q36701474-8243EE38-0A75-4E22-9B46-6ECF7ECC739BQ36739767-AAC95948-CDED-4818-9052-9B81E3EC0B31Q36753313-4E451C08-51E3-4845-B169-DE2A230A9301Q37033216-9789193A-8AC0-46AC-845A-81039781779CQ37038352-BE5A3BF2-7141-4E51-BDC3-1A0BE6A34E29Q37139142-AA5BD0A8-9572-4DFB-9C87-A6A7851DD6B2Q37165194-F94322EB-DCB8-4F74-AF94-6F102CF44313Q37259636-8142F6E8-DE36-4471-A054-AE7D7395E90BQ37363676-D9B7E10A-BEA6-44FA-92C2-148B5DAE5930Q37623726-C4A3D1BE-7177-4134-BFB4-A97A79BFD85CQ37762752-72335924-EEB4-48BF-8219-650B3F13EF93Q37818483-FFCFFAC1-9A2D-4905-96E3-F4407229CAEC
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment of metastatic malignant melanoma.
@ast
Treatment of metastatic malignant melanoma.
@en
type
label
Treatment of metastatic malignant melanoma.
@ast
Treatment of metastatic malignant melanoma.
@en
prefLabel
Treatment of metastatic malignant melanoma.
@ast
Treatment of metastatic malignant melanoma.
@en
P1476
Treatment of metastatic malignant melanoma.
@en
P2093
Ehab Atallah
Lawrence Flaherty
P2888
P304
P356
10.1007/S11864-005-0002-5
P577
2005-05-01T00:00:00Z